3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Head and Neck Neoplasms
2
Virus Diseases
1
Tumor Virus Infections
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Pharyngeal Diseases
1
Papillomavirus Infections
1
Otorhinolaryngologic Neoplasms
1
Otorhinolaryngologic Diseases
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
DNA Virus Infections
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Interventions
Radiotherapy, Intensity-Modulated
4
X-Rays
3
Blood Specimen Collection
3
Surveys and Questionnaires
2
Surgical Procedures, Operative
2
Radiotherapy
2
Radiation
2
Polymerase Chain Reaction
2
Nicotine
2
Magnetic Resonance Spectroscopy
2
Immunohistochemistry
2
Fluorodeoxyglucose F18
2
Acupuncture Therapy
2
iso-sulfan blue
1
fluoromisonidazole
1
Watchful Waiting
1
Varenicline
1
Transcutaneous Electric Nerve Stimulation
1
Technetium Tc 99m Sulfur Colloid
1
Taxes
1
Standard of Care
1
Single Photon Emission Computed Tomography Computed Tomography
1
Sentinel Lymph Node Biopsy
1
Rubidium-82
1
Ropivacaine
1
Referral and Consultation
1
Radiosurgery
1
Pregabalin
1
Practice Guidelines as Topic
1
Oral Hygiene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Oropharyngeal Neoplasms
×
Nimorazole
×
Clear all
NCT04124198
2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA
Active not recruiting
138 enrolled